ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 371

$480K Total Retail Price of All Prescriptions

Rank: 22 out of 371

475 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 475 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 5,138 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $76 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 358 205 1 2
OMEPRAZOLE 348 182 2 3
LEVOTHYROXINE SODIUM 283 177 3 4
HYDROCODONE-ACETAMINOPHEN 282 84 S3 4 11
AMLODIPINE BESYLATE 237 161 5 5
METFORMIN HCL 235 168 6 6
METOPROLOL SUCCINATE 173 99 7 16
LISINOPRIL 170 92 8 1
CRESTOR 167 77 9 25
HYDROCHLOROTHIAZIDE 163 125 10 9
METOPROLOL TARTRATE 163 117 10 8
GABAPENTIN 150 93 12 17
WARFARIN SODIUM 145 82 13 10
PREDNISONE 129 90 14 23
FUROSEMIDE 119 84 15 7
CITALOPRAM HBR 114 67 16 15
AZITHROMYCIN 107 68 17 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 79 18 30
LOSARTAN POTASSIUM 96 57 19 38
ISOSORBIDE MONONITRATE ER 92 76 20 34
PROAIR HFA 89 46 21 51
SERTRALINE HCL 81 29 22 19
ATORVASTATIN CALCIUM 80 59 23 13
MIRTAZAPINE 79 37 24 60
ATENOLOL 79 61 24 14
SPIRIVA 79 40 24 22
PANTOPRAZOLE SODIUM 75 59 27 40
TRICOR 74 24 28 92
KLOR-CON M20 72 60 29 94
ADVAIR DISKUS 70 29 30 21
LOSARTAN-HYDROCHLOROTHIAZIDE 69 43 31 112
ALLOPURINOL 66 29 32 44
TRAMADOL HCL 65 34 33 20
TORSEMIDE 62 47 34 174
CLOPIDOGREL 62 45 34 27
VENLAFAXINE HCL ER 61 31 36 59
COMBIVENT 56 54 37 120
LANTUS SOLOSTAR 55 22 38 39
PLAVIX 50 40 39 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.